Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55

MT NewswiresJun 22 19:09 ET

Hamilton Thorne Maintained at Buy at Stifel GMP Ahead of Q4 Results; Price Target Kept at C$2.75

MT NewswiresMar 26 11:42 ET

Quipt Home Medical Maintained at Buy at Stifel GMP After Fiscal Q1 Results; Price Target Cut to C$10.50

MT NewswiresFeb 16 09:38 ET

Echelon Wealth Partners Maintains Their Buy Rating on Hamilton Thorne (HTL)

TipRanksOct 10, 2023 16:20 ET

Echelon Wealth Partners Reaffirms Their Buy Rating on Quipt Home Medical (QIPT)

TipRanksOct 3, 2023 07:40 ET

Quipt Home Medical (QIPT) Receives a Buy From Echelon Wealth Partners

TipRanksSep 11, 2023 12:40 ET

Echelon Wealth Partners Maintains Their Buy Rating on Sernova (SVA)

TipRanksSep 5, 2023 13:10 ET

Quipt Home Medical (QIPT) Gets a Buy Rating From Echelon Wealth Partners

TipRanksAug 15, 2023 11:20 ET

Lake Street Maintains a Buy Rating on Profound Medical (PRN)

TipRanksAug 10, 2023 09:20 ET

Sernova (SVA) Receives a Buy From H.C. Wainwright

TipRanksJun 26, 2023 06:20 ET

Profound Medical Corp Is Maintained at Outperform by Raymond James

Dow JonesAug 8, 2022 12:40 ET

Profound Medical Corp. Is Maintained at Outperform by Raymond James

Dow JonesJul 18, 2022 14:01 ET